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Background
Despite the growing interest and use of MSK-US in chil-
dren, its current use in paediatric rheumatology is not
known.
Objectives
To identify the current use of MSK-US and the areas
most suitable for its development and standardisation in
paediatric rheumatology.
Methods
A questionnaire of 10 single or composite questions,
including professional data, current use in daily practice,
current clinical relevance of the main features of MSK-
US, and areas for prospective development, has been
sent to the members of PRINTO/PRES.
Results
92/389 (24%) answers have been collected from 37
countries. The responders are mainly pediatric rheuma-
tologists (80%), have a long-lasting clinical experience in
paediatric rheumatology (74% >10 years), and are more
clinicians (>70%) than researchers (24%).
MSK-US is used in clinical practice by>90%: person-
ally by 40%, 49% by the radiologist, 16% by the adult
rheumatologist. The most relevant features of MSK-US
are the high patient’s acceptability (76%), the immediate
improving of diagnosis of joint and soft tissue disease
(73%), the assessment of synovitis and tendons/
tendons’sheaths (73% and 70%), and the support to ima-
ging guided joint injections (67%). The anatomical sites
best suited for MSK-US are hips (87%), ankles (78%),
wrists (65%), knees (64%), and mid-foot (63%). MSK-US
is considered important for diagnosis, therapy monitor-
ing, and research (70%).
Conclusions
We identified the current use of MSK-US in paediatric
rheumatology among the European network of
PRINTO/PRES. The results outline the major reasons
and areas of interest, useful for future steps towards a
wider international standardized development of MSK-
US in paediatric rheumatology.
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